Projects per year
Fingerprint
Dive into the research topics where Jodi Carter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Mayo Clinic Breast Cancer SPORE
Chen, J., Couch, F. J., Gendler, S. J., Ingle, J. N., Lingle, W. L., Suman, V. J., Vachon, C. M., Goetz, M. M. P., Degnim, A. C., Vachon, C. C. M., Galanis, E., Haluska, P. R. J., Hawse, J. R., Carter, J., Chen, J. J., Sherman, M. E., Visscher, D. W. & Wang, L. M.
9/22/05 → 8/31/24
Project: Research project
-
-
Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era
Sherman, M. E., Vierkant, R. A., Winham, S. J., Vachon, C. M., Carter, J., Pacheco-Spann, L., Jensen, M. R., McCauley, B. M., Hoskin, T. L., Seymour, L., Gehling, D., Fischer, J., Ghosh, K., Radisky, D. C. & Degnim, A. C., 2024, (Accepted/In press) In: JAMA surgery.Research output: Contribution to journal › Article › peer-review
-
Neuromuscular choristoma and circumferential nerve territory desmoid-type fibromatosis: imaging findings supporting a nerve-driven mechanism
Maldonado, A. A., Broski, S. M., Carter, J. M., Marek, T., Howe, B. M. & Spinner, R. J., Jan 1 2024, In: Journal of neurosurgery. 140, 1, p. 1-9 9 p.Research output: Contribution to journal › Article › peer-review
-
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer
Carter, J. M., Chumsri, S., Hinerfeld, D. A., Ma, Y., Wang, X., Zahrieh, D., Hillman, D. W., Tenner, K. S., Kachergus, J. M., Brauer, H. A., Warren, S. E., Henderson, D., Shi, J., Liu, Y., Joensuu, H., Lindman, H., Leon-Ferre, R. A., Boughey, J. C., Liu, M. C., Ingle, J. N., & 6 others , Dec 2023, In: Nature communications. 14, 1, 2215.Research output: Contribution to journal › Article › peer-review
Open Access -
Evaluation of Alisertib Alone or Combined with Fulvestrant in Patients with Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial
Haddad, T. C., Suman, V. J., D'Assoro, A. B., Carter, J. M., Giridhar, K. V., McMenomy, B. P., Santo, K., Mayer, E. L., Karuturi, M. S., Morikawa, A., Marcom, P. K., Isaacs, C. J., Oh, S. Y., Clark, A. S., Mayer, I. A., Keyomarsi, K., Hobday, T. J., Peethambaram, P. P., O'Sullivan, C. C., Leon-Ferre, R. A., & 3 others , Jun 15 2023, In: JAMA Oncology. 9, 6, p. 815-824 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Frequency of HER2 protein overexpression and HER2 gene amplification in endometrial clear cell carcinoma
Sukov, W. R., Zhou, J., Geiersbach, K. B., Keeney, G. L., Carter, J. M. & Schoolmeester, J. K., Jul 2023, In: Human Pathology. 137, p. 94-101 8 p.Research output: Contribution to journal › Article › peer-review